Bibliography
- Hanes J , DemeesterJ. Drug and gene delivery to mucosal tissues: the mucus barrier. Adv. Drug Deliv. Rev.61(2), 73–74 (2009).
- Yang Y , TsifanskyM, Wu C-J, Yang HI, Schmidt G, Yeo Y. Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis. Pharm. Res.27(1), 151–160 (2010).
- Edwards DA , HanesJ, CaponettiGet al. Large porous particles for pulmonary drug delivery. Science 276(5320), 1868–1871 (1997).
- Edwards DA , Ben-JebriaA, LangerR. Recent advances in pulmonary drug delivery using large, porous inhaled particles. J. Appl. Physiol.85(2), 379–385 (1998).
- Kim TK , YoonJJ, LeeDS, ParkTG. Gas foamed open porous biodegradablepolymeric microspheres. Biomaterials27(2), 152 (2006).
- Jeon S , LeeC, OhMet al. Recombinant basic fibroblast growth factor inhibits the airway hyperresponsiveness, mucus production, and lung inflammation induced by an allergen challenge. J. Allergy Clin. Immunol. 119(4), 831–837 (2007).
- Park SW , ShinS, KimCHet al. Differential effects of insufflated, subcutaneous, and intravenous growth hormone on bone growth, cognitive function, and NMDA receptor subunit expression. Endocrinology 151(9), 4418–4427 (2010).
- Ibrahim BM , JunSW, LeeMY, KangSH, YeoY. Development of inhalable dry powder formulation of basic fibroblast growth factor. Int. J. Pharm.385, 66–72 (2010).
- Xu P , QuickG, YeoY. Gene delivery through the use of a hyaluronate-associated intracellularly degradable cross-linked polyethyleneimine. Biomaterials30(29), 5834–5843 (2009).
- Gullotti E , YeoY. Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery. Mol. Pharm.6(4), 1041–1051 (2009).
- Xu P , GullottiE, TongLet al. Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited. Mol. Pharm. 6(1), 190–201 (2009).
- Xu P , BajajG, ShuggT, Van Alstine WG, Yeo Y. Zwitterionic chitosan derivatives for pH-sensitive stealth coating. Biomacromolecules11(9), 2352–2358 (2010).
- Bajaj G , YeoY. Drug delivery systems for intraperitoneal therapy. Pharm. Res.27(5), 735–738 (2010).
- Rickett T , AmoozgarZ, SunW, YeoY, ShiR. A photo-crosslinkable chitosan hydrogel for peripheral nerve anastomosis. Proceedings of the 2009 2nd International Conference on Biomedical Engineering and Informatics. J. Med. Syst.1–4, 1078–1082 (2009).
- Rask F , DallabridaSM, IsmailNSet al. Photocrosslinkable chitosan modified with angiopoietin-1 peptide, QHREDGS, promotes survival of neonatal rat heart cells. J. Biomed. Mater. Res. A 95(1), 105–117 (2010).
- Yeo Y , GengW, ItoT, KohaneDS, BurdickJ, RadisicM. A photocrosslinkable hydrogel for myocyte cell culture and injection. J. Biomed. Mater. Res. Part B Appl. Biomater.81(2), 312–322 (2006).
- Yeo Y , AdilM, BellasE, AstashkinaA, ChaudharyN, KohaneDS. Prevention of peritoneal adhesions with an in situ cross-linkable hyaluronan hydrogel delivering budesonide. J. Control. Release120(3), 178–185 (2007).
- Yeo Y , BellasE, HighleyCB, LangerR, KohaneDS. Peritoneal adhesion prevention with an in situ cross-linkable hyaluronan gel containing tissue-type plasminogen activator in a rabbit repeated injury model. Biomaterials28(25), 3704–3713 (2007).
- Shi R , BorgensRB, BlightAR. Functional reconnection of severed mammalian spinal cord axons with polyethylene glycol. J. Neurotrauma16(8), 727–738 (1999).